摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-bromo-N-methyl-N-phenylpropanamide | 1225744-16-0

中文名称
——
中文别名
——
英文名称
3-bromo-N-methyl-N-phenylpropanamide
英文别名
3-Bromo-N-methyl-N-phenylpropanamide
3-bromo-N-methyl-N-phenylpropanamide化学式
CAS
1225744-16-0
化学式
C10H12BrNO
mdl
——
分子量
242.115
InChiKey
NUCBHVZZAYLCPE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-bromo-N-methyl-N-phenylpropanamide6-乙氧基-2,2,4-三甲基-1,2-二氢喹啉碳酸氢钠 、 potassium iodide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 以82%的产率得到3-[(2R,6R,11R)-8-hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-methyl-N-phenylpropanamide
    参考文献:
    名称:
    Evaluation of N-substitution in 6,7-benzomorphan compounds
    摘要:
    6,7-Benzomorphan derivatives, exhibiting different mu, delta, and kappa receptor selectivity profiles depending on the N-substituent, represent a useful skeleton for the synthesis of new and better analgesic agents. In this work, an aromatic ring and/or alkyl residues have been used with an N-propanamide or N-acetamide spacer for the synthesis of a new series of 5,9-dimethyl-2'-hydroxy-6,7-benzomorphan derivatives (12-22). Data obtained by competition binding assays showed that the mu opioid receptor seems to prefer an interaction with the 6,7-benzomorphan ligands having an N-substituent with a propanamide spacer and less hindered amide. Highly stringent features are required for delta receptor interaction, while an N-acetamide spacer and/or bulkier amide could preferentially lead to kappa receptor selectivity. In the propanamide series, compound 12 (named LP1) displayed high mu affinity (K(i) = 0.83 nM), good delta affinity (K(i) = 29 nM) and low affinity for the kappa receptor (K(i) = 110 nM), with a selectivity ratio delta/mu and kappa/mu of 35.1 and 132.5, respectively. Further, in the adenylyl cyclase assay, LP1 displayed a mu/delta agonist profile, with IC(50) values of 4.8 and 12 nM at the mu and delta receptors, respectively. The antinociceptive potency of LP1 in the tail-flick test after sc administration in rat was comparable with the potency of morphine (ED(50) = 2.03 and 2.7 mg/kg, respectively), and was totally reversed by naloxone. LP1, possessing a mu/delta agonist profile, could represent a lead in further developing benzomorphan-based ligands with potent in vivo analgesic activity and a reduced tendency to induce side effects. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.06.005
  • 作为产物:
    描述:
    N-甲基-N-苯基丙烯酰胺三(三甲基硅基)硅烷1,2-二溴乙烷 作用下, 以 乙酸乙酯 为溶剂, 反应 18.0h, 以65%的产率得到3-bromo-N-methyl-N-phenylpropanamide
    参考文献:
    名称:
    光诱导卤原子转移:卤化物自由基选择性卤化氢反应的生成
    摘要:
    描述了第一个能够通过卤素原子转移 (XAT) 产生卤化物自由基的光介导过程。这种新颖的反应模式依赖于使用 1,2-二卤乙烷通过 XAT 生成不稳定的碳自由基,XAT 在 β 断裂后释放卤化物自由基,这些卤化物自由基已用于不饱和烃的选择性卤化氢。
    DOI:
    10.1002/chem.202201495
点击查看最新优质反应信息

文献信息

  • Bench-Stable Stock Solutions of Silicon Grignard Reagents: Application to Iron- and Cobalt-Catalyzed Radical C(sp<sup>3</sup> )-Si Cross-Coupling Reactions
    作者:Weichao Xue、Ryosuke Shishido、Martin Oestreich
    DOI:10.1002/anie.201807640
    日期:2018.9.10
    the preparation of silicon‐based magnesium reagents is reported. The MgBr2 used in the lithium‐to‐magnesium transmetalation step is generated in situ from 1,2‐dibromoethane and elemental magnesium in hot THF. No precipitation of MgBr2 occurs in the heat, and transmetalation at elevated temperature leads to homogeneous stock solutions of the silicon Grignard reagents that are stable and storable in the
    据报道,一种可靠的制备硅基镁试剂的方法。锂到镁的过渡金属化步骤中使用的MgBr 2是由1,2-二溴乙烷和元素镁在热THF中原位生成的。加热过程中不会发生MgBr 2的沉淀,并且在高温下的金属转移会导致硅格氏试剂的均质储备溶液,该溶液在冰箱中稳定且可储存。该方法避免了制备硅原核试剂,例如Si-Si和Si-B试剂。新的格氏试剂被用于前所未有的铁和钴催化的未活化烷基溴的交叉偶联反应。这些镁试剂的官能团耐受性极佳。
  • Design, synthesis and structure–activity relationships of novel benzoxazolone derivatives as 18kDa translocator protein (TSPO) ligands
    作者:Takayuki Fukaya、Toru Kodo、Takeo Ishiyama、Hiroyoshi Kakuyama、Hiroyuki Nishikawa、Satoko Baba、Shuji Masumoto
    DOI:10.1016/j.bmc.2012.07.023
    日期:2012.9
    Selective 18 kDa translocator protein (TSPO) ligands are expected to be therapeutic agents with a wide spectrum of action on psychiatric disorders and fewer side effects. We designed novel benzoxazolone derivatives and examined the structure–activity relationship (SAR) of a series of compounds with various substituents at the amide part and C-5 position. Although a number of the synthesized compounds
    选择性的18 kDa转运蛋白(TSPO)配体有望成为对精神疾病具有广泛作用且副作用较少的治疗剂。我们设计了新颖的苯并恶唑酮衍生物,并研究了在酰胺部分和C-5位置具有多个取代基的一系列化合物的结构-活性关系(SAR)。尽管许多合成的化合物显示出高的TSPO结合亲和力,但这些化合物的药物样性质较差。这些化合物的药代动力学特性的进一步优化导致发现化合物74,该化合物在大鼠Vogel冲突模型中表现出抗焦虑作用。
  • Evaluation of N-substitution in 6,7-benzomorphan compounds
    作者:Lorella Pasquinucci、Orazio Prezzavento、Agostino Marrazzo、Emanuele Amata、Simone Ronsisvalle、Zafiroula Georgoussi、Danai-Dionysia Fourla、Giovanna M. Scoto、Carmela Parenti、Giuseppina Aricò、Giuseppe Ronsisvalle
    DOI:10.1016/j.bmc.2010.06.005
    日期:2010.7
    6,7-Benzomorphan derivatives, exhibiting different mu, delta, and kappa receptor selectivity profiles depending on the N-substituent, represent a useful skeleton for the synthesis of new and better analgesic agents. In this work, an aromatic ring and/or alkyl residues have been used with an N-propanamide or N-acetamide spacer for the synthesis of a new series of 5,9-dimethyl-2'-hydroxy-6,7-benzomorphan derivatives (12-22). Data obtained by competition binding assays showed that the mu opioid receptor seems to prefer an interaction with the 6,7-benzomorphan ligands having an N-substituent with a propanamide spacer and less hindered amide. Highly stringent features are required for delta receptor interaction, while an N-acetamide spacer and/or bulkier amide could preferentially lead to kappa receptor selectivity. In the propanamide series, compound 12 (named LP1) displayed high mu affinity (K(i) = 0.83 nM), good delta affinity (K(i) = 29 nM) and low affinity for the kappa receptor (K(i) = 110 nM), with a selectivity ratio delta/mu and kappa/mu of 35.1 and 132.5, respectively. Further, in the adenylyl cyclase assay, LP1 displayed a mu/delta agonist profile, with IC(50) values of 4.8 and 12 nM at the mu and delta receptors, respectively. The antinociceptive potency of LP1 in the tail-flick test after sc administration in rat was comparable with the potency of morphine (ED(50) = 2.03 and 2.7 mg/kg, respectively), and was totally reversed by naloxone. LP1, possessing a mu/delta agonist profile, could represent a lead in further developing benzomorphan-based ligands with potent in vivo analgesic activity and a reduced tendency to induce side effects. (C) 2010 Elsevier Ltd. All rights reserved.
  • Photo‐Induced Halogen‐Atom Transfer: Generation of Halide Radicals for Selective Hydrohalogenation Reactions
    作者:Lilian Geniller、Marc Taillefer、Florian Jaroschik、Alexis Prieto
    DOI:10.1002/chem.202201495
    日期:2022.8
    The first photo-mediated process enabling the generation of halide radicals by halogen-atom transfer (XAT) is described. This novel reactivity pattern relies on the use of 1,2-dihaloethanes for the generation of unstable carbon radicals by XAT, which after β-scission, release halide radicals that have been used in selective hydrohalogenations of unsaturated hydrocarbons.
    描述了第一个能够通过卤素原子转移 (XAT) 产生卤化物自由基的光介导过程。这种新颖的反应模式依赖于使用 1,2-二卤乙烷通过 XAT 生成不稳定的碳自由基,XAT 在 β 断裂后释放卤化物自由基,这些卤化物自由基已用于不饱和烃的选择性卤化氢。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐